-
'At home' Djokovic makes winning return in Athens
-
Manchester City have become 'more beatable', says Dortmund's Gross
-
Merino brace sends Arsenal past Slavia in Champions League
-
Djokovic makes winning return in Athens
-
Napoli and Eintracht Frankfurt in Champions League stalemate
-
Arsenal's Dowman becomes youngest-ever Champions League player
-
Cheney shaped US like no other VP. Until he didn't.
-
Pakistan edge South Africa in tense ODI finish in Faisalabad
-
Brazil's Lula urges less talk, more action at COP30 climate meet
-
Barca's Lewandowski says his season starting now after injury struggles
-
Burn urges Newcastle to show their ugly side in Bilbao clash
-
French pair released after 3-year Iran jail ordeal
-
EU scrambles to seal climate targets before COP30
-
Getty Images largely loses lawsuit against UK AI firm
-
Cement maker Lafarge on trial in France over jihadist funding
-
Sculpture of Trump strapped to a cross displayed in Switzerland
-
Pakistan's Rauf and Indian skipper Yadav punished over Asia Cup behaviour
-
Libbok welcomes 'healthy' Springboks fly-half competition
-
Reeling from earthquakes, Afghans fear coming winter
-
Ronaldo reveals emotional retirement will come 'soon'
-
Munich's surfers stunned after famed river wave vanishes
-
Iran commemorates storming of US embassy with missile replicas, fake coffins
-
Gauff sweeps Paolini aside to revitalise WTA Finals defence
-
Shein vows to cooperate with France in probe over childlike sex dolls
-
Young leftist Mamdani on track to win NY vote, shaking up US politics
-
US government shutdown ties record for longest in history
-
King Tut's collection displayed for first time at Egypt's grand museum
-
Typhoon flooding kills over 40, strands thousands in central Philippines
-
Trent mural defaced ahead of Liverpool return
-
Sabalenka to face Kyrgios in 'Battle of Sexes' on December 28
-
Experts call for global panel to tackle 'inequality crisis'
-
Backed by Brussels, Zelensky urges Orban to drop veto on EU bid
-
After ECHR ruling, Turkey opposition urges pro-Kurd leader's release
-
Stocks drop as tech rally fades
-
UK far-right activist Robinson cleared of terror offence over phone access
-
World on track to dangerous warming as emissions hit record high: UN
-
Nvidia, Deutsche Telekom unveil 1-bn-euro AI industrial hub
-
Which record? Haaland warns he can get even better
-
Football star David Beckham hails knighthood as 'proudest moment'
-
Laurent Mauvignier wins France's top literary award for family saga
-
Indian Sikh pilgrims enter Pakistan, first major crossing since May conflict
-
Former US vice president Dick Cheney dies at 84
-
Fiorentina sack Pioli after winless start in Serie A
-
Stocks drop as traders assess tech rally
-
Oscar-winning Palestinian films daily 'Israeli impunity' in West Bank
-
Spain's Telefonica shares drop on dividend cut, net loss
-
Fierce mountain storms kill nine in Nepal
-
Divisive Czech cardinal Dominik Duka dies at 82
-
Shein vows to cooperate with France in sex doll probe
-
EU in last-ditch push to seal climate targets before COP30
Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
E.AbuRizq--SF-PST